CGRP antagonists
Artikelen filtered by tag "CGRP antagonists"
The following articles contain the tag CGRP antagonists:
New drug: lasmiditan for migraine attacks
Two new drugs for the acute treatment of migraine attacks were authorised in 2022. They concern the ‘calcitonin gene-related peptide’ (CGRP) antagonist rimegepant, which was previously discussed in Ge-Bu, and the 5HT1F agonist lasmiditan. New age ...
New drug: rimegepant for migraine attacks
Two million people in the Netherlands regularly experience migraine. In addition to preventive medication, a large proportion of patients also use drugs for the acute treatment of a migraine attack. The cornerstone of this therapy are the triptan ...
New drugs for migraine prophylaxis
The discovery of the role of ‘calcitonin gene-related peptide’ (CGRP) in the development of migraine enabled new drugs for the treatment of this condition to be developed. The monoclonal CGRP antagonists erenumab, fremanezumab and galcanezumab ha ...
